CELL AND GENE THERAPY INSIGHTS

January 2019 Issue

Volume 5 Issue 1

Cell and Gene Therapy Insights Volume 5 Issue 1
Download PDF

Featuring

Issue Spotlight: Cell Therapy Quality/ CMC & Analytics
Vectors focus: Non Viral Delivery Methods 2019
Other articles

SPOTLIGHT

Cell Therapy Quality/ CMC & Analytics
Greg Russotti
Guest Editor:
Greg Russotti, Vice President, Technical Operations at Celgene Corporation

Expert Insight

Standards Landscape in Cell Counting: Implications for Cell & Gene Therapy

Standards Landscape in Cell Counting: Implications for Cell & Gene Therapy

S Sarkar, L Pierce, S Lin-Gibson et al.
15 February 2019
Read
Using Machine Learning for Critical Quality Attribute Discovery in Cell Therapy Manufacture

Using Machine Learning for Critical Quality Attribute Discovery in Cell Therapy Manufacture

Dan Charles Wilkinson, Stefan Irion
14 February 2019
Read
How to Reduce the Vein to Vein Timeframe Through Efficient, Accelerated QC & Release Testing

How to Reduce the Vein to Vein Timeframe Through Efficient, Accelerated QC & Release Testing

Adrian P Gee
14 February 2019
Read

Perspective

An Academic Model for Cell & Gene Therapy Asset Development

An Academic Model for Cell & Gene Therapy Asset Development

David DiGiusto
14 February 2019
Read

Interview

Critical considerations & common mistakes in early-phase CMC development

Critical considerations & common mistakes in early-phase CMC development

Jason Carstens
18 February 2019
Read
European regulator’s perspective: best practice & future directions in cell therapy CMC

European regulator’s perspective: best practice & future directions in cell therapy CMC

Margarida Menezes Ferreira
15 February 2019
Read
Next steps in MSC cell therapy characterization

Next steps in MSC cell therapy characterization

Bruce Bunnell
15 February 2019
Read
Optimizing quality & compliance for cord blood-derived cells

Optimizing quality & compliance for cord blood-derived cells

Roger Horton, Chris Leonforte
15 February 2019
Read

Vectors FOCUS

Non Viral Delivery Methods 2019

Innovator Insight

Non-Viral Vector Mediated Gene Delivery: the Outsider to Watch Out For in Gene Therapy

Non-Viral Vector Mediated Gene Delivery: the Outsider to Watch Out For in Gene Therapy

A Nyamay’Antu, M Dumont, V Kedinger et al.
18 February 2019
Read

Interview

DNA Vectors – a Key Enabler of Tomorrow’s Cancer Immunotherapies

DNA Vectors – a Key Enabler of Tomorrow’s Cancer Immunotherapies

Richard Paul Harbottle
5 February 2019
Read
In vivo electroporation: the key to unlocking the power of DNA-encoded vaccines and monoclonal antibodies

In vivo electroporation: the key to unlocking the power of DNA-encoded vaccines and monoclonal antibodies

Trevor Smith
4 February 2019
Read
Progressing Non-Viral Gene Therapy Approaches in GI Tract & Bladder Diseases

Progressing Non-Viral Gene Therapy Approaches in GI Tract & Bladder Diseases

Anthony Cheung
4 February 2019
Read
The Future of Non-Viral Delivery: Niche Player or Gene Therapy Cornerstone?

The Future of Non-Viral Delivery: Niche Player or Gene Therapy Cornerstone?

Lynn Zechiedrich
4 February 2019
Read

articles

Commercial Insights

Cell & Gene Therapy Commercial Insight – January 2019

Cell & Gene Therapy Commercial Insight – January 2019

Mark Curtis, Richard Philipson
27 February 2019
Read